5/23/2018

Investigational Gout Drugs Do Well in Clinical Trials

Investigational Gout Drugs Do Well in Clinical Trials

Two major American drug companies are racing to get rival new gout medications to market. Both gout medicines take novel approaches to treating refractory gout - gout that hasn't already responded well to be able to current treatment.

Ardea Biosciences had been the first to announce productive clinical trials of its experimental gout drug RDEA594, also referred to as Lesinurad. Lesinurad's mechanism of action is different from that of the commonly prescribed xanthine oxidase inhibitors gout medications (such as allopurinol and febuxostat), which decrease the development of uric acid.

Lesinurad is often a URAT1 transporter inhibitor which usually raises reduction of uric acid through the kidneys. Lesinurad is also active in opposition to another important regulator of urate secretion, OAT4. OAT4 is thought to be responsible for the high uric acid levels in gouty arthritis patients whose condition is caused or worsened by diuretics.

Gout ¦ Definition, Causes, Symptoms and Treatment

gout definition causes symptoms treatment Gout Treatment and Symptoms gout treatment النقرس gout definition, gout pdf, gout ppt, gout symptoms, gout ...

The Lesinurad study involved 208 gout patients who had high blood urate levels for at least A few months, even while taking the gout drug allopurinol. Sufferers continued on allopurinol and were randomly assigned to receive either a placebo or lesinurad at doses of 200 mg, 400 mg, or 600 mg for four weeks.

All three groups who were given lesinurad confirmed considerably lower uric acid levels at the conclusion of the month. The percentage of patients who achieved the target for uric acid levels after treatment was 28% in the placebo group, 71% in the 200 mg team, 76% in the 400 mg team, and 87% in the 600 mg group.

Remedies for High Uric Acid

Remedies for High Uric Acid

Goutezol Gout Relief is formulated with herbal ingredients developed to support healthy uric acid metabolism. Goutezol includes only the best quality ingredients that have been scientifically formulated to work for optimal results. Goutezol's ingredients have been used safely for many years to support healthy uric acid metabolism, helping in reducing high uric acid levels. Now they are all combined into this unique gout formula. Lowering uric acid and supporting uric acid metabolism has been shown to eliminate the discomfort and flare-ups related to gout.
Click Here to Read More »

More recently, gives of BioCryst Pharmaceuticals rose 12% upon the release of the results of its phase 2b randomized, double-blind, study of the investigational gout drug BCX4208. BCX4208 is really a novel enzyme inhibitor that acts upstream of xanthine oxidase in the purine metabolism pathway to reduce serum uric acid (sUA).

  • SesamoiditisSesamoiditis Sesamoiditis is an inflammatory condition of the sesamoid bones which are located on the plantar (bottom) aspect of the first metatarsal phalangeal joint (1st MPJ or big toe joint).Treatment of SesamoiditisConservative treatment of...
  • Its mechanism of action complements xanthine oxidase inhibitors such as allopurinol and febuxostat in reducing uric acid production, and BCX4208 is intended as an add-on therapy for those gouty arthritis patients who don't respond well in order to current gout medication.

    Like Lesinurad, BCX4208 was studied in gouty arthritis patients who had experienced high blood urate levels for at least 6 months, despite taking the gout drug allopurinol. The 279 study participants were randomly assigned to take BCX4208 at doses of either 5 mg, 10 mg, 20 mg, or 40 mg once daily for 12 weeks. One group of individuals was given a placebo. Just about all participants were also given allopurinal 300 mg once-daily.

    • All but one of the doses showed that BCX4208 was superior to the placebo when taken with allopurinol.
    • The BCX4208 doses evaluated in the study showed response rates ranging from 33% to be able to 49%, compared to 18% for those taking the placebo.

    At this point, Lesinurad appears the more promising of the two gout drugs, and the most likely to hit the market first. That outperformed BCX4208 in early clinical trials, and is farther ahead in the development and approval process. But individual responses to drugs vary, and gout patients will benefit from having two new approaches to relieving the symptoms of this painful condition.

    Alex Ray Advocates for Affordable Access to Healthcare and Medication

    She recommends Big Mountain Drugs as a trusted on the internet Canadian pharmacy from which to buy allopurinol and colchicine for gout. For more information about gout and gout medication, go to the on the internet source www.colchicine.ca.